Lead ions do not cause human lung cells to escape chromate-induced cytotoxicity

被引:39
作者
Holmes, AL
Wise, SS
Xie, H
Gordon, N
Thompson, WD
Wise, JP
机构
[1] Univ So Maine, Biosci Res Inst, Ctr Integrated & Appl Environm Toxicol, Portland, ME 04104 USA
[2] Univ So Maine, Biosci Res Inst, Wise Lab Environm & Genet Toxicol, Portland, ME 04104 USA
[3] Univ So Maine, Dept Chem, Portland, ME 04104 USA
[4] Univ So Maine, Dept Appl Sci Med, Portland, ME 04104 USA
关键词
chromate; lead; cytotoxicity; particulate;
D O I
10.1016/j.taap.2004.08.006
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Hexavalent chromium (Cr (VI)) compounds are established human lung carcinogens: Solubility plays a key role in Cr (VI) carcinogenicity, with the most potent carcinogens being water-insoluble or `particulate'. Lead chromate is used as the prototypical particulate Cr (VI) compound since it is the most insoluble of these compounds. Previous work in our laboratory showed that lead chromate particles dissolve outside cells to produce chromium (Cr) and lead (Pb) ions and that the Cr ions were genotoxic. Pb has been hypothesized to play an epigenetic role in the carcinogenic activity of lead chromate, perhaps by allowing Cr-damaged cells to survive, however, this possibility has not been investigated. Accordingly, we determined the functional role of Pb and Cr ions in lead chromate-induced clonogenic survival. We found that vitamin C co-treatment eliminated Cr ion uptake, had only a slight effect on Pb ion levels, and eliminated lead chromate cytotoxicity. These data indicate that Cr ions caused the cytotoxicity. We found that lead chromate and soluble Cr (VI) induced similar amounts of cytotoxicity indicating that Pb does not play an epigenetic role and cause Cr-damaged cells to survive. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:167 / 176
页数:10
相关论文
共 28 条
[1]
[Anonymous], 1990, IARC Monogr Eval Carcinog Risks Hum, V49, P1
[2]
Induction of apoptotic cell death by particulate lead chromate: Differential effects of vitamins C and E on genotoxicity and survival [J].
Blankenship, LJ ;
Carlisle, DL ;
Wise, JP ;
Orenstein, JM ;
Dye, LE ;
Patierno, SR .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 146 (02) :270-280
[3]
Carlisle DL, 2000, MOL CARCINOGEN, V28, P111, DOI 10.1002/1098-2744(200006)28:2<111::AID-MC7>3.0.CO
[4]
2-Y
[5]
Apoptosis and p53 induction in human lung fibroblasts exposed to chromium (VI): Effect of ascorbate and tocopherol [J].
Carlisle, DL ;
Pritchard, DE ;
Singh, J ;
Owens, BM ;
Blankenship, LJ ;
Orenstein, JM ;
Patierno, SR .
TOXICOLOGICAL SCIENCES, 2000, 55 (01) :60-68
[6]
Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity [J].
Chuang, SM ;
Liou, GY ;
Yang, JL .
CARCINOGENESIS, 2000, 21 (08) :1491-1500
[7]
GENOTOXICITY OF CHROMIUM COMPOUNDS - A REVIEW [J].
DEFLORA, S ;
BAGNASCO, M ;
SERRA, D ;
ZANACCHI, P .
MUTATION RESEARCH, 1990, 238 (02) :99-172
[8]
DEFLORA S, 1989, LIFE CHEM REPORTS, V7, P169
[10]
INDIRECT MECHANISM OF LEAD-INDUCED GENOTOXICITY IN CULTURED-MAMMALIAN-CELLS [J].
HARTWIG, A ;
SCHLEPEGRELL, R ;
BEYERSMANN, D .
MUTATION RESEARCH, 1990, 241 (01) :75-82